FTSE 250 movers: Genus soars on FDA green light; Mobico tanks again

By Frank Prenesti

Date: Wednesday 30 Apr 2025

(Sharecast News) - FTSE 250 (MCX) 19,755.34 -0.27%






Animal genetics company Genus surged after the US Food and Drug Administration (FDA) approved its PRP gene edit under its PRRS Resistant Pig ("PRP") programme for use in the U.S. food supply chain.

Mobico tanked again after poor results this week.



Market Movers


FTSE 250 - Risers

Genus (GNS) 1,886.00p 18.92%
Senior (SNR) 136.40p 2.25%
Drax Group (DRX) 614.00p 2.08%
SSP Group (SSPG) 146.00p 1.88%
European Opportunities Trust (EOT) 854.00p 1.79%
Ninety One (N91) 147.40p 1.66%
Marshalls (MSLH) 279.00p 1.64%
Patria Private Equity Trust (PPET) 571.00p 1.42%
Clarkson (CKN) 3,270.00p 1.40%
Pennon Group (PNN) 499.40p 1.26%

FTSE 250 - Fallers

Mobico Group (MCG) 28.94p -9.45%
PPHE Hotel Group Ltd (PPH) 1,260.00p -5.26%
Carnival (CCL) 1,207.50p -4.13%
IP Group (IPO) 42.10p -3.88%
Dr. Martens (DOCS) 54.35p -3.55%
Aston Martin Lagonda Global Holdings (AML) 67.60p -3.29%
THG (THG) 24.50p -2.93%
Syncona Limited NPV (SYNC) 90.70p -2.68%
Wizz Air Holdings (WIZZ) 1,627.00p -2.52%
BH Macro Ltd. GBP Shares (BHMG) 391.50p -2.37%

« Go back to news channel

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE